Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. I.C. (Isabelle) van Gelder

Publicaties

Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study

Atrial fibrillation screening: time for precision, not just detection

Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Risk prediction of atrial fibrillation progression in patients with paroxysmal atrial fibrillation: data from the RACE V study

Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Atrial arrhythmia and heart failure in congenital heart disease: A pas de deux with consequences

Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association

Pers/media

Remote ECG Screening Ups Atrial Fibrillation Detection ‘Modestly’

Hart op hol, geen paniek.

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 8 – Fatsoenlijk werk en economische groeiSDG 9 – Industrie, innovatie en infrastructuurSDG 13 – Klimaatactie

Meer informatie over de Sustainable Development Goals.